1055101

Michael J. Downing, M.D. — FEI 3014256731

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
May 30, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Dallas, TX (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
756021 CFR 312.60FD-1572, protocol compliance